Current Report Filing (8-k)
June 04 2019 - 4:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
Date of report (Date of earliest event
reported):
June 4, 2019 (May 31, 2019)
APOLLO MEDICAL HOLDINGS, INC.
(Exact Name of Registrant as Specified
in Charter)
Delaware
|
|
001-37392
|
|
95-4472349
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
1668 S. Garfield Avenue, 2nd Floor, Alhambra,
CA 91801
(Address of Principal Executive Offices,
and Zip Code)
(626) 282-0288
Registrant’s Telephone Number,
Including Area Code
|
(Former Name or Former Address, if Changed Since Last Report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction
A.2. below):
|
¨
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock
|
AMEH
|
Nasdaq Capital Market
|
Indicate by check mark whether the
registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2
of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 8.01 Other Events.
On June 4, 2019, Apollo Medical Holdings,
Inc. (the “Company”), an integrated population health management company, issued a press release announcing that Allied
Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California (“APC”), and APC-LSMA
Designated Shareholder Medical Corporation (“APC-LSMA”), have completed their acquisition of Alpha Care Medical Group,
Inc. (“Alpha Care”). Under the terms of the stock purchase agreement (“SPA”) APC and APC-LSMA acquired
100% of the capital stock of Alpha Care from Dr. Kevin Tyson for an aggregate purchase price of $45,000,000 in cash, subject to
post-closing adjustments, as defined under the SPA.
A copy of the press release is attached
as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial
Statements and Exhibits
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities
and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
APOLLO MEDICAL HOLDINGS, INC.
|
|
|
Dated: June 4, 2019
|
By:
|
/s/ Thomas S. Lam, M.D
|
|
Name:
|
Thomas S. Lam, M.D
|
|
Title:
|
Chief Executive Officer
|
Apollo Medical (NASDAQ:AMEH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Apollo Medical (NASDAQ:AMEH)
Historical Stock Chart
From Apr 2023 to Apr 2024